Stay updated with breaking news from Abcam cambridge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abcam plc (OTCMKTS:ABCZF – Get Rating) saw a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 31,400 shares, a decline of 77.4% from the May 15th total of 139,200 shares. Based on an average daily trading volume, of 200 shares, the short-interest ratio is […] ....
Abcam (NASDAQ:ABCM – Get Rating) and MeiraGTx (NASDAQ:MGTX – Get Rating) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation and analyst recommendations. Earnings & Valuation This table compares Abcam and MeiraGTx’s top-line revenue, earnings […] ....
Abcam plc (LON:ABC – Get Rating) insider Mara G. Aspinall acquired 3,037 shares of the company’s stock in a transaction dated Monday, April 4th. The shares were purchased at an average cost of GBX 1,436 ($18.83) per share, for a total transaction of £43,611.32 ($57,195.17). ABC stock traded down GBX 0.15 ($0.00) during midday trading […] ....
Abcam (NASDAQ:ABCM – Get Rating) and Inhibikase Therapeutics (NYSE:IKT – Get Rating) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Profitability This table compares Abcam and Inhibikase Therapeutics’ net margins, return […] ....
CAMBRIDGE, England, March 25, 2022 /PRNewswire/ Abcam (AIM:ABC); (NASDAQ:ABCM), today announced that it has received six recognitions from CiteAb at their annual industry awards ....